• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确保临床试验中高质量治疗的实施——跨塔斯曼放射肿瘤学组(TROG)03.04“雷达”设置准确性研究的结果。

Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.

作者信息

Haworth Annette, Kearvell Rachel, Greer Peter B, Hooton Ben, Denham James W, Lamb David, Duchesne Gillian, Murray Judy, Joseph David

机构信息

Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.

出版信息

Radiother Oncol. 2009 Mar;90(3):299-306. doi: 10.1016/j.radonc.2008.10.011. Epub 2008 Nov 18.

DOI:10.1016/j.radonc.2008.10.011
PMID:19017549
Abstract

BACKGROUND AND PURPOSE

A multi-centre clinical trial for prostate cancer patients provided an opportunity to introduce conformal radiotherapy with dose escalation. To verify adequate treatment accuracy prior to patient recruitment, centres submitted details of a set-up accuracy study (SUAS). We report the results of the SUAS, the variation in clinical practice and the strategies used to help centres improve treatment accuracy.

MATERIALS AND METHODS

The SUAS required each of the 24 participating centres to collect data on at least 10 pelvic patients imaged on a minimum of 20 occasions. Software was provided for data collection and analysis. Support to centres was provided through educational lectures, the trial quality assurance team and an information booklet.

RESULTS

Only two centres had recently carried out a SUAS prior to the trial opening. Systematic errors were generally smaller than those previously reported in the literature. The questionnaire identified many differences in patient set-up protocols. As a result of participating in this QA activity more than 65% of centres improved their treatment delivery accuracy.

CONCLUSIONS

Conducting a pre-trial SUAS has led to improvement in treatment delivery accuracy in many centres. Treatment techniques and set-up accuracy varied greatly, demonstrating a need to ensure an on-going awareness for such studies in future trials and with the introduction of dose escalation or new technologies.

摘要

背景与目的

一项针对前列腺癌患者的多中心临床试验为引入剂量递增的适形放疗提供了契机。为在患者招募前验证治疗的足够准确性,各中心提交了摆位准确性研究(SUAS)的详细资料。我们报告了SUAS的结果、临床实践中的差异以及用于帮助各中心提高治疗准确性的策略。

材料与方法

SUAS要求24个参与中心中的每个中心收集至少10例盆腔患者的数据,这些患者至少接受20次成像。提供了用于数据收集和分析的软件。通过教育讲座、试验质量保证团队和一本信息手册为各中心提供支持。

结果

只有两个中心在试验开始前最近进行了SUAS。系统误差通常小于先前文献报道的误差。调查问卷发现患者摆位方案存在许多差异。由于参与了这项质量保证活动,超过65%的中心提高了其治疗实施的准确性。

结论

开展试验前的SUAS已使许多中心的治疗实施准确性得到提高。治疗技术和摆位准确性差异很大,这表明在未来试验以及引入剂量递增或新技术时,需要确保持续关注此类研究。

相似文献

1
Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.确保临床试验中高质量治疗的实施——跨塔斯曼放射肿瘤学组(TROG)03.04“雷达”设置准确性研究的结果。
Radiother Oncol. 2009 Mar;90(3):299-306. doi: 10.1016/j.radonc.2008.10.011. Epub 2008 Nov 18.
2
High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.欧洲的高适形放疗:31个中心参与欧洲癌症研究与治疗组织(EORTC)前列腺癌试验22991的质量保证计划。
Eur J Cancer. 2004 Nov;40(16):2411-6. doi: 10.1016/j.ejca.2004.07.019.
3
Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.多机构三维放射治疗临床试验质量保证的初步经验。简要报告。
Strahlenther Onkol. 1998 Oct;174 Suppl 2:40-2.
4
Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.澳大利亚和新西兰前列腺癌三维适形放疗:放疗中心调查及共识研讨会会议记录报告
Australas Radiol. 2004 Dec;48(4):502-8. doi: 10.1111/j.1440-1673.2004.01355.x.
5
Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.22961 项欧洲癌症研究与治疗组织(EORTC)试验的质量保证。一项关于促性腺激素释放激素(LHRH)类似物与放射治疗联合应用于局部晚期前列腺癌治疗的最佳激素辅助治疗组合的 III 期研究:预试验。
Radiother Oncol. 2004 Oct;73(1):11-20. doi: 10.1016/j.radonc.2004.08.005.
6
Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.前列腺癌放射治疗的质量改进:TROG 03.04“雷达”试验期间全面质量保证的结果与影响
J Med Imaging Radiat Oncol. 2013 Apr;57(2):247-57. doi: 10.1111/1754-9485.12025. Epub 2013 Jan 7.
7
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.22991 项欧洲癌症研究与治疗组织(EORTC)泌尿生殖系统肿瘤组(ROG)局部前列腺癌试验中的质量保证:预试验和个案审查
Radiother Oncol. 2009 Mar;90(3):285-90. doi: 10.1016/j.radonc.2008.10.022. Epub 2008 Nov 27.
8
EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.欧洲癌症研究与治疗组织22972-26991/英国医学研究理事会BR10试验:高级别胶质瘤常规放疗后的分次立体定向增敏放疗。立体定向增敏放疗组的临床及质量保证结果
Radiother Oncol. 2008 Aug;88(2):163-72. doi: 10.1016/j.radonc.2008.03.025. Epub 2008 Apr 30.
9
Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.复杂放射治疗临床试验计划数据的详细回顾与分析:SWAN软件系统的评估及初步经验
Radiother Oncol. 2008 Feb;86(2):200-10. doi: 10.1016/j.radonc.2007.11.013.
10
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.实施英国医学研究理事会(MRC)RT01试验(国际标准随机对照试验编号:47772397):局部前列腺癌男性患者适形放疗随机对照试验的方法与实际情况
Radiother Oncol. 2004 Aug;72(2):199-211. doi: 10.1016/j.radonc.2004.04.007.

引用本文的文献

1
An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group.日本临床肿瘤学会-放射治疗研究组医学物理工作组对放疗多中心临床试验中与医学物理相关的验证系统的概述。
J Radiat Res. 2020 Nov 16;61(6):999-1008. doi: 10.1093/jrr/rraa089.
2
Quality improvement process to assess tattoo alignment, set-up accuracy and isocentre reproducibility in pelvic radiotherapy patients.评估盆腔放疗患者纹身对齐、设置准确性和等中心可重复性的质量改进过程。
J Med Radiat Sci. 2014 Dec;61(4):246-252. doi: 10.1002/jmrs.79. Epub 2014 Nov 21.
3
Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial.
治疗计划与实施因素对胃肠道毒性的影响:来自RADAR前列腺癌放疗试验的数据分析
Radiat Oncol. 2014 Dec 13;9:282. doi: 10.1186/s13014-014-0282-7.
4
Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative.国家层面放射治疗的质量保证:来自挪威的经验——KVIST倡议
J Radiother Pract. 2014 Mar;13(1):35-44. doi: 10.1017/S1460396912000544. Epub 2013 Apr 22.
5
Quality assurance for clinical trials.临床试验的质量保证。
Front Oncol. 2013 Dec 19;3:311. doi: 10.3389/fonc.2013.00311.
6
Evaluation of combining bony anatomy and soft tissue position correction strategies for IMRT prostate cancer patients.调强放射治疗前列腺癌患者时联合骨解剖结构与软组织位置校正策略的评估
Rep Pract Oncol Radiother. 2012 Feb 9;17(2):104-9. doi: 10.1016/j.rpor.2012.01.005. eCollection 2012.
7
Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303.多中心局部晚期食管癌随机临床试验的放射治疗质量保证审查:日本临床肿瘤学组(JCOG)试验 0303。
Int J Clin Oncol. 2012 Apr;17(2):105-11. doi: 10.1007/s10147-011-0264-9. Epub 2011 Jun 14.
8
Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.局部前列腺癌的放射治疗与雄激素剥夺治疗联合应用——批判性评价。
Curr Oncol. 2010 Oct;17(5):28-38. doi: 10.3747/co.v17i5.632.